206 results on '"Mason, Emily F."'
Search Results
2. Flow Cytometric Assessment of Malignant Hematologic Disorders
3. PD-1H/VISTA mediates immune evasion in acute myeloid leukemia
4. LAIR-1 agonism as a therapy for acute myeloid leukemia
5. Thrombotic Microangiopathy Due to Progressive Disseminated Histoplasmosis in a Child With Down Syndrome and Acute Lymphoblastic Leukemia
6. Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group
7. Cell-programmed nutrient partitioning in the tumour microenvironment
8. Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment
9. PD-1H/VISTA mediates immune evasion in acute myeloid leukemia
10. TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia
11. Distinct bone marrow findings associated with a noncanonical UBA1 variant in VEXAS syndrome.
12. Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome
13. Exploiting Tumor Necrosis Factor Aberrations in Marginal Zone Lymphoma
14. Diagnostic Utility of CD200 Immunohistochemistry in Distinguishing EBV-Positive Large B-Cell Lymphoma From Classic Hodgkin Lymphoma
15. Supplementary File 1 from PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis
16. Data from PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis
17. PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in patients with Myelofibrosis
18. Supplementary Figures 1-9 from Aerobic Glycolysis Suppresses p53 Activity to Provide Selective Protection from Apoptosis upon Loss of Growth Signals or Inhibition of BCR-Abl
19. Data from Aerobic Glycolysis Suppresses p53 Activity to Provide Selective Protection from Apoptosis upon Loss of Growth Signals or Inhibition of BCR-Abl
20. Supplementary Figure Legends 1-9 from Aerobic Glycolysis Suppresses p53 Activity to Provide Selective Protection from Apoptosis upon Loss of Growth Signals or Inhibition of BCR-Abl
21. Contributing Authors
22. Programmed Death-1 Homolog (PD-1H/VISTA) Blockade Confers a Synergistic Anti-Leukemia Effect with PD-1 Blockade
23. Extranodal Marginal Zone Lymphomas Show Recurrent Mutations in DNA Repair Genes, Cancer-Associated Proliferative Signaling and NOTCH1 Signaling Pathways, Regardless of Anatomic Site
24. TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia
25. Secondary‐type mutations do not impact prognosis in acute myelogenous leukemia AML with mutated NPM1
26. Thrombotic Microangiopathy Due to Progressive Disseminated Histoplasmosis in a Child With Down Syndrome and Acute Lymphoblastic Leukemia
27. COVID monoclonal antibody therapy detected by serum immunofixation electrophoresis
28. Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group.
29. Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis
30. Oligoclonal Gamma‐delta T cell expansion in response to Ehrlichia infection
31. Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy
32. A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AML
33. Chronic myeloid leukemia with pure erythroid leukemia blast crisis
34. Update on Pediatric and Young Adult Mature Lymphomas
35. Pediatric hematolymphoid pathology in the gastrointestinal tract
36. Malaise, Weight Loss, and Acute Kidney Injury in a 13-year-old Girl
37. Isocitrate dehydrogenase inhibitor‐driven differentiation may resemble secondary graft failure in post‐allogeneic haematopoietic cell transplantation relapsed acute myeloid leukaemia
38. Oncofetal Protein SALL4 Is Highly Expressed in Myelodysplastic Syndrome Alongside with NAT10 and P53
39. Durable Long-Term Response in a Patient With Diffuse Large B-Cell Lymphoma Treated With Nivolumab
40. Chronic myeloid leukemia with pure erythroid leukemia blast crisis.
41. Primary central nervous system erythroid sarcoma with NFIA‐CBFA2T3 translocation: A rare but distinct clinicopathologic entity
42. Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma
43. Combination of Nivolumab, Lenalidomide and Rituximab in Relapsed/Refractory Non-Germinal Center Diffuse Large B Cell Lymphoma: Results from a Dose-Escalation Cohort
44. Bone Marrow Morphologic Findings in Patients Receiving IDH Inhibitor Therapy in Combination with Intensive Induction Chemotherapy: Challenges with Interpretation of the Day 14 Bone Marrow Biopsy
45. TP53Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia
46. Myelodysplastic/myeloproliferative neoplasm with eosinophilia as a manifestation of Li Fraumeni Syndrome
47. Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms
48. 52. A rare (7;12) translocation resulting in a rearrangement of the IKZF1 locus with concurrent deletion of CDKN2A, CDKN2B and PAX5 loci: an unannotated genetic abnormality in pediatric B-lymphoblastic leukemia/lymphoma
49. Case 3: Priapism in a 13-year-old Boy
50. Hematopoietic Neoplasms of the Sinonasal Tract
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.